-
Healthcare
-

Palantir To Remain In Nhs Until 2029 As Ministers Delay Exit

By
Distilled Post Editorial Team

Ministers told MPs on Monday that Palantir's contract to run the NHS federated data platform will end in March 2029. They had the option of leaving next spring, under a break clause that select committee chairs and campaigners had urged them to use, and they declined it. The announcement pleased few people. Critics of the American company complained of delay, and anyone responsible for hospital data will have noticed that a date now exists for a transition without a named successor.

James Frith, the health minister, gave three reasons for the timetable, among them public trust in NHS technology, an end to dependence on one supplier and a chance for British firms to supply critical digital infrastructure. Chi Onwurah, who chairs the Commons science and technology committee, called the extension deeply disappointing. A Liberal Democrat MP said the Palantir contract would leave a firm co-founded by Peter Thiel holding the keys to health data for years to come. Amnesty International, which had campaigned for the earlier exit, called the decision a victory all the same. The ethical objections to Palantir's work with American immigration enforcement and the Israeli military are on the record and ministers will go on being asked about them.

The argument for the longer timetable is easier to dismiss in a Commons exchange than to answer in a trust. The platform links patient and operational information across providers and supports waiting list management, discharge coordination and theatre scheduling. Such tools cannot be removed on a Friday and replaced on a Monday. An exit next spring with no ready alternative would have meant a hurried tender or a retreat to patchwork local systems, at a time when trusts are under sustained pressure to raise productivity and shorten waiting times. Ministers are entitled to prefer an orderly handover.

The case for urgency rests on confidence, and the service has been candid about its own doubts. Many trusts declined to use the platform, often because they had already built local systems that suited their pathways. That is a reasonable response from managers and clinicians who answer for the safety of their services. Frith's remark that the process must command clinical confidence as well as public trust amounted to an admission as much. NHS England's removal of a claim that 137 trusts were benefiting from the platform, after it emerged that 29 of them used it rarely or never, was the correct response to an awkward discovery. It also shows how easily a national programme can count a trust as a user without demonstrating that the trust gains anything. Whatever follows will need measures of success that frontline staff recognise.

Procurement is where the 2029 decision will be won or lost. Ministers say they will soon invite British companies to bid. The ambition is understandable, and the domestic market for national-scale health data infrastructure is young. Few UK firms have delivered a platform of this breadth across more than a hundred trusts with different systems, governance arrangements and levels of digital maturity. A competition that rewards British origin without testing capacity could hand an enormous risk to a small supplier. Whitehall has its own history here. The National Programme for IT, dismantled in 2011 after consuming billions, still shapes how officials think about large health technology contracts, and it should inform the design of this one. Ben Coleman, a Labour member of the health committee, put the danger directly when he said the handover must avoid creating a new dependence on a single supplier.

The sounder design makes the supplier matter less. Open standards, enforced data portability, modular components and contractual rights to move without penalty would let the NHS change provider as routinely as it changes any other contractor. Several firms, each responsible for a defined layer of the platform, would offer more resilience than a single prime contractor, though they would require stronger integration management at the centre. That expertise resides within the NHS and the Department of Health and Social Care, making it a limited resource. Commercial specialists, clinical informaticians and data engineers will need to be funded and retained well beyond the signing of new contracts, which is an uncomfortable demand in a period of tight departmental budgets.

Health technology and life sciences businesses have long described the NHS as a difficult customer. A well-specified competition with transparent evaluation criteria and realistic timetables would answer that complaint more effectively than any strategy document. Those who win a share of the work will inherit a public that watches data security closely and takes an interest in who owns and runs the companies behind it. Firms will need to say plainly where data is held, who may access it and how misuse would be detected.

Patients can expect little change in their care before 2029. They can reasonably ask how their information is protected during the extension and what safeguards will govern the transfer. Ministers have long maintained that the NHS remains in control of the data held on the platform, and that claim will carry weight only if it is backed by published governance arrangements and independent audit. Public confidence in health data has never been secured by reassurance alone.

The two years ahead should not be read as a reprieve for a contractor or as a delay for its own sake. They are the time available to build something the service can rely on and, if necessary, replace. A successor that arrives in 2029 with the same single-supplier structure under a different name would reopen the whole argument. One that arrives on open foundations, designed with clinicians and judged by results reported without embellishment, would show the wait was worth it. The test of the policy is whether, by 2029, changing the supplier of NHS data infrastructure has become an ordinary commercial decision rather than a political crisis.